X hits on this document

Word document

The usefulness and use of second-generation - page 49 / 81





49 / 81

schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry 1997; 154:457-465.

116 Tollefson GD, Sanger TM, Lu Y, Thieme ME. Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol. Arch Gen Psychiatry 1998; 55:250-258.

117 Tollefson GD, Beasley CM, Jr., Tamura RN, et al. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. Am J Psychiatry 1997; 154:1248-1254.

118 Weisler RH, Ahearn EP, Davidson JR, Wallace CD. Adjunctive use of olanzapine in mood disorders: five case reports. Ann Clin Psychiatry 1997; 9:259-262.

119 Beasley CM, Dellva MA, Tamura RN, , et al. Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol. Br J Psychiatry 1999; 174:23-30.

120 Conley RR, Love RC, Kelly DL, Bartko JJ. Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine. Am J Psychiatry 1999; 156:863-868.

121 Sanger TM, Lieberman JA, Tohen M, , et al. Olanzapine versus haloperidol treatment in first-episode psychosis. Am J Psychiatry 1999; 156:79-87.

122 Hamilton SH, Revicki DA, Genduso LA, Beasley CM, Jr. Olanzapine versus placebo and haloperidol: quality of life and efficacy results of the North American double-blind trial. Neuropsychopharmacology 1998; 18:41-49.

123 Tollefson GD, Sanger TM, Beasley CM, Tran PV. A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia. Biol Psychiatry 1998; 43:803-810.

124 Glazer WM. Olanzapine and the new generation of antipsychotic agents: patterns of use. J Clin Psychiatry 1997; 58 (Suppl 10):18-21.

125 Tollefson GD, Sanger TM. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine. Am J Psychiatry 1997; 154:466-474.

126 Tran PV, Hamilton SH, Kuntz AJ, et al. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J Clin Psychopharmacol 1997; 17:407-418.

Document info
Document views327
Page views327
Page last viewedMon Jan 23 17:28:58 UTC 2017